Patent ID: 11939335
Assignee: 858 THERAPEUTICS, INC.
Field: Organic fine chemistry (Chemistry)
Classification: CPC C | IPC A  C

Claim 18:
19. The compound of claim 1, or a pharmaceutically acceptable salt, deuteroisotope, or stereoisomer thereof, wherein R2 is C2-C5 alkynyl, wherein the C2-C5 alkynyl is optionally substituted with one or more substituents independently selected from the group consisting of D, halo, CN, NO2, C(O)Ra, C(O)N(Ra)2, C(O)ORa, N(Ra)2, NRaC(O)Ra, NRaC(O)ORa, NRaS(O)tRa, ORa, OC(O)Ra, OC(O)N(Ra)2, OC(O)ORa, ORcC(O)N(Ra)2, ═O, S(O)tRa, S(O)tN(Ra)2, S(O)tORa, ═S, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl.